R866





                       SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549
                                       
                                       
                                  FORM 10-Q/A


                AMMENDMENT TO APPLICATION OR REPORT FILED PURSUANT
     TO SECTION 12, 13, OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934
                                       
              For the quarterly period ended September 30, 1994
                         Commission File No. 2-70197
                                       
                           OCEAN BIO-CHEM, INC.                           
               (Exact name of registrant as specified in its charter)
                                       
                Florida                                    59-1564329     
       (State or other jurisdiction of                (I.R.S. Employer
       incorporation or organization)                  Identification No.)
                                       
      4041 S. W. 47 Avenue, Ft. Lauderdale, FL                  33314   
     (Address of principal executive offices)                 (Zip Code)

   The undersigned registrant hereby amends the following items, financial 
statements, exhibits or other portions of this quarterly report for the period 
ended September 30, 1994 as set forth in the pages attached hereto.

                                     INDEX

Item 2  Management's Discussion and Analysis of                Page  2
        Financial Condition and Results of Operations
   


















                             OCEAN BIO-CHEM, INC.
                               AND SUBSIDIARIES
                NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS




Item 2.     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
            FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Liquidity and Capital Resources

The primary sources of the Registrant's liquidity are its operations and short 
term borrowings from a commercial lender. Currently the Registrant has available
a line of credit for $1,500,000 and a 30 month note for $350,000 that expires in
July 1995.  The note requires monthly payment of principal plus 1% interest over
prime.

The Registrant is involved in making sales in the Canadian market and  must  
deal with the currency fluctuations of the Canadian currency. The Registrant 
does not  engage in currency hedging and deals with such currency risk as a 
pricing issue.

During the past few years Registrant has introduced various new products to the 
market. This has required the Registrant to carry greater amounts of overall 
inventory and has resulted in lower inventory turnover rates. The effects of 
such inventory turnover have not been material to the overall operations of 
Registrant. Registrant believes that all required capital to maintain such
increases can continue to be provided from operations and current lending 
arrangements.



Pursuant to the requirements of the Securities and exchange Act of
1934, the registrant has duly caused this mendment to be signed on its
behalf by the undersigned, thereunto duly authorized.

Date September 1, 1995


/s/ PETER DORNAU        
Peter Dornau, President













                                     -2-